Back to index
Oakwood Labs

Oakwood Labs

oakwoodlabs.comPharmaceutical Development

What AI says about Oakwood Labs

Oakwood Labs specializes in the development and manufacturing of sustained-release injectable formulations using their proprietary Chroniject™ technology. With over 25 years of experience, they provide end-to-end solutions for pharmaceutical companies, ensuring quality and compliance throughout the drug development process.

Is this your brand?

Claim this profile to keep your information accurate and add what's missing.

Products & Services

Sustained Release Injectable Development

Development and manufacturing of long-acting injectable formulations using the Chroniject™ technology platform.

Contract Development and Manufacturing Services

Full-service contract development and manufacturing organization (CDMO) services for sustained release pharmaceuticals.

Common Questions

What is Chroniject™ technology?

Chroniject™ is Oakwood Labs' proprietary polymer microsphere-based drug delivery technology that enables controlled release of active pharmaceutical ingredients over extended periods.

What types of molecules can be encapsulated?

The Chroniject™ platform is compatible with small molecules, peptides, and proteins.

What are the benefits of long-acting injectables?

Long-acting injectables reduce injection frequency, improve patient compliance, target specific anatomical areas, and help prevent drug abuse.

Where is Oakwood Labs located?

Oakwood Labs is based in the Cleveland, Ohio area.

What regulatory standards does Oakwood Labs adhere to?

Oakwood Labs adheres to rigorous cGMP practices and maintains high standards of quality and regulatory compliance.

Company Information

Founded
1997
Headquarters
Cleveland, Ohio area
Employees
51-200
Industries
PharmaceuticalsDrug DeliveryCDMO